Daily Market Updates: Bristol Myers Squibb's Cancer Breakthrough Could Have Implications Beyond Its Own Stock

Earnings

Home›Earnings›Results›Bristol Myers Squibb's Cancer Breakthrough Could Have…

Bristol Myers Squibb's Cancer Breakthrough Could Have Implications Beyond Its Own Stock

Reported · Written up by our desk · Results

Bristol-Myers Squibb's iza-bren cut breast cancer progression risk by up to 38% in a Phase 3 trial, lifting shares and raising implications for rivals like Exelixis.

← Newer storyRevolut plans private company investment offering Older story →China: Strong current account backs Chinese Yuan appreciation - Stand…

More like this

EarningsBoeing shares slide on a disappointing cash flow update. Why this dip is buyable

EarningsCoca-Cola Stock Is Everything AI Isn’t,And That’s Its Biggest Strength

EarningsApple's Foldable iPhone Sold Out in Minutes, But Wall Street Has Questions

EarningsNetflix Is Making Big Changes, But Can It Fix What's Really Hurting Growth?

EarningsCharging Ahead: Solid Power’s Pilot Line Leaves the Lab

Sources

MarketBeat RatingsBristol Myers Squibb's Cancer Breakthrough Could Have Implications Beyond Its Own Stock

Earnings

Bristol Myers Squibb's Cancer Breakthrough Could Have Implications Beyond Its Own Stock

More like this

Sources

Get the close, explained.